News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
760,207 Results
Type
Article (45725)
Company Profile (333)
Press Release (714131)
Multimedia
Podcasts (126)
Webinars (22)
Section
Business (212574)
Career Advice (2122)
Deals (36577)
Drug Delivery (136)
Drug Development (82784)
Employer Resources (177)
FDA (17074)
Job Trends (15448)
News (357858)
Policy (33638)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2749)
Accelerated approval (47)
Adcomms (26)
Allergies (176)
Alliances (52624)
ALS (213)
Alzheimer's disease (1827)
Antibody-drug conjugate (ADC) (464)
Approvals (17444)
Artificial intelligence (714)
Autoimmune disease (298)
Automation (58)
Bankruptcy (367)
Best Places to Work (11930)
BIOSECURE Act (20)
Biosimilars (222)
Biotechnology (221)
Bladder cancer (190)
Brain cancer (72)
Breast cancer (760)
Cancer (5889)
Cardiovascular disease (475)
Career advice (1805)
Career pathing (43)
CAR-T (346)
CDC (58)
Celiac Disease (3)
Cell therapy (935)
Cervical cancer (47)
Clinical research (71651)
Collaboration (2142)
Company closure (6)
Compensation (1404)
Complete response letters (80)
COVID-19 (2829)
CRISPR (115)
C-suite (1154)
Cystic fibrosis (158)
Data (7940)
Decentralized trials (3)
Denatured (45)
Depression (164)
Dermatology (87)
Diabetes (591)
Diagnostics (7216)
Digital health (57)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (334)
Drug pricing (203)
Drug shortages (33)
Duchenne muscular dystrophy (290)
Earnings (93820)
Editorial (67)
Employer branding (22)
Employer resources (157)
Events (124439)
Executive appointments (1115)
FDA (20856)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (34)
Funding (1781)
Gene editing (250)
Generative AI (63)
Gene therapy (757)
GLP-1 (1074)
Government (4839)
Grass and pollen (7)
Guidances (411)
Healthcare (19723)
HIV (83)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (292)
Immuno-oncology (94)
Indications (192)
Infectious disease (3176)
Inflammatory bowel disease (223)
Inflation Reduction Act (14)
Influenza (140)
Intellectual property (296)
Interviews (331)
IPO (17014)
IRA (51)
Job creations (3836)
Job search strategy (1502)
JPM (62)
Kidney cancer (19)
Labor market (101)
Layoffs (579)
Leadership (41)
Legal (8177)
Liver cancer (101)
Longevity (32)
Lung cancer (765)
Lymphoma (432)
Machine learning (63)
Management (63)
Manufacturing (1072)
MASH (187)
Medical device (14683)
Medtech (14809)
Mergers & acquisitions (20818)
Metabolic disorders (1511)
mRNA (229)
Multiple sclerosis (187)
NASH (17)
Neurodegenerative disease (425)
Neuropsychiatric disorders (105)
Neuroscience (3356)
Neurotech (1)
NextGen: Class of 2026 (6855)
Non-profit (4668)
Now hiring (78)
Obesity (704)
Opinion (301)
Ovarian cancer (223)
Pain (254)
Pancreatic cancer (304)
Parkinson's disease (366)
Partnered (34)
Patents (608)
Patient recruitment (683)
Peanut (65)
People (61876)
Pharmaceutical (67)
Pharmacy benefit managers (32)
Phase 1 (22497)
Phase 2 (31542)
Phase 3 (23375)
Pipeline (8804)
Policy (325)
Postmarket research (2587)
Preclinical (9675)
Press Release (71)
Prostate cancer (304)
Psychedelics (54)
Radiopharmaceuticals (344)
Rare diseases (1089)
Real estate (6300)
Recruiting (70)
Regulatory (26037)
Reports (56)
Research institute (2555)
Resumes & cover letters (365)
Rett syndrome (39)
RNA editing (24)
RSV (89)
Schizophrenia (179)
Series A (303)
Series B (218)
Service/supplier (14)
Sickle cell disease (114)
Special edition (23)
Spinal muscular atrophy (167)
Sponsored (49)
Startups (3907)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (87)
The Weekly (78)
Vaccines (1136)
Venture capital (114)
Weight loss (457)
Women's health (128)
Worklife (20)
Date
Last 7 days (873)
Last 30 days (3414)
Last 365 days (30758)
2026 (12708)
2025 (30957)
2024 (36209)
2023 (41132)
2022 (52397)
2021 (56991)
2020 (55610)
2019 (48406)
2018 (36438)
2017 (33539)
2016 (33138)
2015 (39357)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (782)
Alabama (96)
Alaska (7)
Arizona (361)
Arkansas (16)
Asia (42407)
Australia (7065)
California (13493)
Canada (3790)
China (1374)
Colorado (578)
Connecticut (592)
Delaware (415)
Europe (93438)
Florida (1997)
Georgia (440)
Hawaii (3)
Idaho (65)
Illinois (1083)
India (91)
Indiana (610)
Iowa (24)
Japan (546)
Kansas (135)
Kentucky (53)
Louisiana (42)
Maine (76)
Maryland (1609)
Massachusetts (9722)
Michigan (392)
Minnesota (737)
Mississippi (7)
Missouri (156)
Montana (36)
Nebraska (29)
Nevada (146)
New Hampshire (91)
New Jersey (3545)
New Mexico (31)
New York (3518)
North Carolina (1733)
North Dakota (11)
Northern California (6737)
Ohio (408)
Oklahoma (25)
Oregon (45)
Pennsylvania (2696)
Puerto Rico (30)
Rhode Island (51)
South America (1170)
South Carolina (86)
South Dakota (2)
Southern California (5323)
Tennessee (214)
Texas (2155)
United States (47782)
Utah (404)
Vermont (1)
Virginia (329)
Washington D.C. (81)
Washington State (1091)
West Virginia (4)
Wisconsin (139)
Wyoming (2)
760,207 Results for "paragonix technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Paragonix Technologies LIVERguard® Used in Cross-Country Donor Liver Transplant Case
May 13, 2025
·
3 min read
Press Releases
Paragonix Launches Initiative to Increase Donor Lung Utilization
April 24, 2025
·
4 min read
Genetown
Paragonix Technologies Announces Nationwide Commercial Availability of FDA-Cleared BAROguard™ Donor Lung Preservation System
Paragonix Technologies, Inc. announces the full commercial launch of its next-generation transport device, the BAROguard™ Donor Lung Preservation System.
April 4, 2024
·
4 min read
Press Releases
Paragonix to Spotlight Breakthrough Research in Solid Organ Transplantation at the 2025 World Transplant Congress
July 28, 2025
·
4 min read
Press Releases
UCI Health Partner with Sierra Donor Services to Expand Kidney Transplant Opportunities Utilizing Paragonix KidneyVault Preservation Technology
May 29, 2025
·
4 min read
Genetown
Paragonix Technologies Unveils Expansive Organ Procurement Network
Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the launch of a comprehensive network of donor organ procurement, preservation, and transportation services.
November 28, 2023
·
4 min read
Press Releases
New Study Reports Increased 4-Year Survival in Heart Transplant Patients when Utilizing the Paragonix SherpaPak System
April 30, 2025
·
5 min read
Genetown
Paragonix Unveils PancreasPak™: The World’s First FDA-Cleared Preservation Device for Donor Pancreas Transplantation
Paragonix Technologies, a leader in organ transplant technology, proudly announces the PancreasPak™ Organ Preservation System, the first FDA-cleared device designed to protect and monitor donor pancreases during transportation.
June 27, 2024
·
3 min read
Genetown
Paragonix Presenting Expansive Organ Transplant Research at the International Society of Heart and Lung Transplantation 44th Annual Meeting
Paragonix Technologies, Inc., a pioneer in organ transplant products and services, is honored to announce the forthcoming release of new clinical data supporting the use of controlled hypothermic preservation and clinical services.
March 21, 2024
·
4 min read
Genetown
Paragonix LUNGguard System Shown to Reduce Post-Transplant Complications in Lung Transplant Recipients
Paragonix Technologies, Inc., a pioneer in organ transplant technologies and services, presented impactful clinical data on the use of its Advanced Organ Preservation system, LUNGguard®, in the largest real-world multi-center study presented at the 44th ISHLT Annual Meeting and Scientific Sessions – one of the largest international conferences focused on advanced treatment for end-stage heart and lung disease
April 10, 2024
·
5 min read
1 of 76,021
Next